MarketCap
Facebook
X
TelegramTekla Healthcare Investors Financial Ratios 2020-2011 | HQH
Brief overview of Tekla Healthcare Investors's valuation multiples
Ratios are assessed across five available annual reports in the 2011–2014 interval.
The latest available valuation ratios are P/E 4.84x (median 4.11x), P/B 1.02x (median 0.97x), P/CF 33.23x (median 19.68x). On average, this basket is 17.7% above its own five-year medians. The market is pricing in elevated future expectations.
At the current P/E, inverse earnings yield is 20.7%, a useful bridge between price and business earnings.
End-period return metrics are ROE 21.1%, ROA 21.1%. Returns on capital and assets point to efficient economics and a strong internal source of growth.
PEG of 0.16x shows valuation is not outpacing embedded growth. The conclusion depends on earnings durability.
For this sector, valuation ratios are useful only alongside capital adequacy, reserves and credit-portfolio quality.
What the ratios show
Tekla Healthcare Investors's high quality ratios explain part of the market premium but increase sensitivity to slower growth.
Annual Financial Ratios Tekla Healthcare Investors
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
- | - | - | - | - | - | 4.8 | 3.4 | 3.0 | 11.3 |
P/S |
- | - | - | - | - | - | 502.3 | 345.4 | 94.2 | 195.9 |
EV/EBITDA |
- | - | - | - | - | - | 2.4 | 1.7 | 3.0 | 8.5 |
PEG |
- | - | - | - | - | - | -0.34 | 0.16 | 0.01 | 0.19 |
P/B |
- | - | - | - | - | - | 1.0 | 1.0 | 0.9 | 1.0 |
P/CF |
- | - | - | - | - | - | -7.6 | 33.2 | 18.0 | 19.7 |
ROE % |
- | - | - | - | - | - | 21.08 | 28.99 | 30.92 | 8.54 |
ROA % |
- | - | - | - | - | - | 21.06 | 28.96 | 30.89 | 8.48 |
DSO |
- | - | - | - | - | - | 1245.1 | 37.2 | 21.7 | 1015.0 |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Tekla Healthcare Investors, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
China
